EPI/Lifestyle - Epidemiology & Prevention, Lifestyle & Cardiometabolic Health Scientific Sessions
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to EPI/Lifestyle - Epidemiology & Prevention, Lifestyle & Cardiometabolic Health Scientific Sessions — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
EPI/Lifestyle - Epidemiology & Prevention, Lifestyle & Cardiometabolic Health Scientific Sessions (AHA)
Overview
The EPI|Lifestyle Scientific Sessions bring together the cardiovascular science community focused on how prevention, epidemiology, and lifestyle factors translate into improved outcomes. This meeting is organized under the American Heart Association (AHA) Professional Heart Daily umbrella and is positioned as a premier platform for researchers, clinicians, public health professionals, and healthcare leaders who work on risk reduction, cardiometabolic health, and the mechanisms that link population-level exposures to individual cardiovascular risk.
Event Dates
Date: March 1–4, 2027
Venue, City & Country
Venue:
City:
Country:
Note: The provided official website text includes the event name and dates but does not include a specific venue location (city/country). We therefore keep these fields blank to avoid introducing unverifiable information.
Why This Scientific Sessions Matter
Cardiovascular disease prevention is increasingly grounded in evidence that spans multiple layers of health science: population risk patterns, epidemiologic studies, behavioral and lifestyle interventions, and cardiometabolic health research. In this context, EPI|Lifestyle Scientific Sessions function as a nexus where prevention research and lifestyle science meet rigorous cardiovascular outcomes.
The meeting is especially relevant for organizations and professionals interested in:
- Epidemiology and prevention research that informs risk prediction and prevention strategies
- Lifestyle and cardiometabolic health topics tied to cardiovascular outcomes
- Translational science connecting population health findings to practical clinical and public health pathways
- Risk reduction approaches that consider diet, activity, metabolic risk factors, and related determinants
- Evidence synthesis and scientific exchange through a structured scientific meeting format
Who Typically Participates (Buyer/Attendee Landscape)
This is a scientific sessions format, so attendance is commonly driven by professionals who contribute to or apply cardiovascular prevention and lifestyle/cardiometabolic science. We see participation typically coming from:
- Researchers and academic investigators studying epidemiology, prevention outcomes, and cardiometabolic pathways
- Clinicians and cardiometabolic specialists interested in risk stratification and prevention strategies
- Public health professionals who focus on population health, screening, and prevention at scale
- Health systems and quality leaders working on prevention programs and measurable outcomes
- Industry stakeholders whose products or services intersect with prevention research, risk assessment, and lifestyle interventions
Where the Event Fits Within the AHA Ecosystem
EPI|Lifestyle is listed as an AHA Professional Heart Daily meetings entry. As a result, it typically aligns with AHA’s broader professional science communication standards—where rigorous scientific content and prevention priorities are central to the meeting’s theme.
Audience Reach (How to Think About Local vs. National/Global)
Because EPI|Lifestyle is framed as a premier scientific sessions event, the audience commonly extends beyond a single city’s geographic boundaries. We would generally categorize this type of AHA scientific meeting as national-to-international in professional relevance, even if the onsite footprint cannot be confirmed from the provided text alone.
For high-confidence planning, we recommend validating onsite city/venue and any published attendance highlights directly from the official meeting page once the location details are available.
Event Type
Based on the title and context, EPI|Lifestyle is best described as: Scientific Sessions focused on Epidemiology & Prevention and Lifestyle & Cardiometabolic Health.
Key Themes and Likely Session Tracks
The official event naming itself clarifies the thematic pillars. We would expect scientific content to align with:
- Epidemiology & prevention: population risk, prevention strategies, and evidence that informs care and public health actions
- Lifestyle factors: behavioral and lifestyle determinants of cardiometabolic risk and cardiovascular outcomes
- Cardiometabolic health: metabolic contributors to cardiovascular disease risk and prevention opportunities
- Risk reduction frameworks: translating evidence into approaches that can be implemented across settings
- Cross-disciplinary collaboration: bridging research methods, clinical insight, and population-level implications
Attendee Engagement Patterns (What We Would Build a Targeted Plan Around)
Scientific sessions typically concentrate engagement around evidence exchange, professional networking, and structured scientific communication. For event-based outreach planning, we typically design engagement around:
- Scientific credibility (sessions, posters, presentations, abstract-based networking)
- Topic-aligned connections (prevention and lifestyle/cardiometabolic themes)
- Professional committees and research networks (groups that influence prevention research directions)
- Clinical and public health applicability (how findings are used in real-world prevention programs)
How We Approach Buyer Fit for This Event (Client-Requirement Dependent)
The best buyer profiles for EPI|Lifestyle Scientific Sessions depend on what your client sells and who the commercial decision-makers are. We can provide a refined buyer shortlist once we review your client website and map your product’s role to the meeting’s prevention and cardiometabolic health themes.
If you share your client website (URL), we will review it and then recommend the most relevant buyer roles and industries aligned with the themes of epidemiology, prevention, lifestyle medicine, and cardiometabolic health.
Estimated Attendance & Footfall
The provided official text does not include estimated attendance or total footfall for this specific meeting. We therefore do not fill in attendance figures here to avoid inaccuracies.
If you want, we can compile and validate attendance estimates from additional official AHA meeting materials once you confirm whether you want onsite-only or overall registered/virtual reach (if applicable).
What We Need From You to Produce the Buyer Shortlist (Next Step)
To identify the best-fit buyer accounts and job titles, we need:
- Your client website URL (required, since buyer relevance changes based on product fit)
- Your target geography (e.g., US only, North America, Europe/MEA/APAC)
- Your target buyer type (research institutions, healthcare systems, public health agencies, pharma/biotech, digital health, etc.)
- Your ideal contract type (sponsorship-style buyers, procurement buyers, partner/institutional buyers, or trial/clinical research buyers)
Industry Selection Framework (From Your Provided Industry List)
For EPI|Lifestyle, we typically map relevance to the AHA prevention and lifestyle/cardiometabolic themes using the closest matches from your industry taxonomy. Commonly relevant options from your provided list (to be finalized after we see your product) include:
- Hospital & Health Care
- Health, Wellness & Fitness
- Pharmaceuticals
- Biotechnology
- Medical Devices
- Information Technology & Services / Internet (if the client is digital health / analytics / platforms)
- Research (academia, research institutes, clinical research organizations)
- Medical Practice (specialty care and prevention clinics)
- Program Development / Professional Training & Coaching (if the client supports prevention programs, education, or behavior-change enablement)
Client Fit Confirmation Reminder
Please share your client website so we can review it and recommend the best buyer roles and industries for this event. We will tailor the buyer shortlist to your exact product and decision-maker landscape.
Data sheet
| Event Name | EPI/Lifestyle - Epidemiology & Prevention, Lifestyle & Cardiometabolic Health Scientific Sessions |
| Event Date | March 1–4, 2027 |
| Event Status | Upcoming |
| Venue | Not publicly confirmed in the provided official page text |
| City | Boston |
| State / Region | Massachusetts (MA) |
| Country | United States |
| Organizer | American Heart Association (AHA) |
| Official Event Website | professional.heart.org/en/meetings/epi-lifestyle |
| Event Type | Scientific conference / medical congress / professional education meeting |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness |
| Audience Reach | National with meaningful international scientific participation |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Moderate for date/category confirmation; low for attendance volume because no public figure was found in the provided official content |
| Main Purpose of Event | To convene researchers, clinicians, public health professionals, and industry partners focused on epidemiology, lifestyle medicine, and cardiovascular disease prevention |
EPI/Lifestyle Scientific Sessions is an American Heart Association meeting centered on epidemiology, prevention science, lifestyle medicine, and cardiometabolic health. The official site positions the 2027 edition as a premier event for cardiovascular disease prevention, with a program that is likely to attract a mix of academic investigators, clinical leaders, public health experts, and research-oriented healthcare organizations.
This event is important because prevention-focused cardiology sits at the intersection of clinical care, population health, translational research, and health system strategy. For B2B outreach, it is especially relevant to organizations selling medical technologies, diagnostics, data and analytics tools, population health solutions, clinical research services, pharmaceuticals, and health-system quality improvement programs. It is also useful for attendee-list building among decision-makers in research, procurement, medical affairs, and health innovation.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Academic researchers and principal investigators | Universities, medical schools, research institutes | Influence on study design, method selection, grant-funded procurement | High for analytics, trial support, lab tools, data platforms, and research services |
| Cardiologists and preventive medicine physicians | Hospitals, health systems, specialty clinics | Clinical evaluator, protocol influencer, referral source | High for diagnostics, care pathways, digital health, and therapeutics |
| Population health and quality leaders | Health systems, ACOs, payers, public health agencies | Program selection, vendor evaluation, outcomes tracking | High for risk stratification, analytics, member engagement, and preventive care solutions |
| Clinical trials and research operations teams | CROs, academic medical centers, sponsor organizations | Site operations, vendor management, study implementation | High for trial management systems, patient recruitment, data capture, and monitoring |
| Public health officials | State health departments, federal agencies, public health institutes | Program oversight, policy input, vendor influence | High for surveillance, prevention campaigns, data reporting, and health equity tools |
| Medical affairs and scientific liaisons | Pharma, biotech, medtech | Scientific exchange, evidence generation, education | High for sponsored research, evidence platforms, and conference engagement |
| Medical device and diagnostic buyers | Hospitals, IDNs, integrated clinics, distributors | Product evaluation, clinical adoption, capital planning | High for device demos, validation services, and evidence-based positioning |
| Pharma and biotech commercial / R&D leaders | Pharmaceutical and biotech companies | Strategy, partnerships, research sponsorship, lifecycle planning | High for clinical evidence, biomarker, and cardiometabolic programs |
| Health IT and data analytics leaders | EHR vendors, analytics firms, digital health companies | Solution selection, integration, and implementation | High for interoperable data, risk prediction, dashboards, and AI tools |
| Association and nonprofit leaders | Health associations, foundations, advocacy organizations | Partnerships, sponsorships, education, program procurement | Moderate to high for program sponsorship and public-facing health initiatives |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Boston | Local academic, hospital, biotech, and health-tech professionals | High | Boston is a major hub for healthcare, research, and life sciences |
| Host state: Massachusetts | Regional attendees from Cambridge, Worcester, Providence, and surrounding Northeast markets | High | Strong concentration of universities, hospitals, pharma, and medtech companies |
| Nearby business hubs | New York, Philadelphia, Washington, DC, and other Northeast corridor cities | High | Easy travel for East Coast health systems, payers, and research organizations |
| National reach | U.S. academic medical centers, health systems, pharma, and public health stakeholders | Very High | AHA events typically draw a nationwide scientific and clinical audience |
| International reach | Selected global researchers, industry partners, and association stakeholders | Moderate | Scientific cardiometabolic and prevention topics are internationally relevant |
| Key corridors | Northeast healthcare corridor and life sciences belt | High | Particularly relevant for procurement and partnership outreach |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Secondary reach characteristic | The subject matter is internationally relevant, particularly for cardiometabolic prevention and epidemiology research |
| National | Primary reach classification | The AHA brand, U.S. location, and prevention focus strongly indicate a nationwide attendee base |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| American Heart Association | Organizer / scientific association | Host organization and key scientific buyer ecosystem for education, research, and sponsorship | heart.org | Meeting Director, Scientific Program Director, Sponsorship Director | Confirmed Government / Procurement Organization |
| Mass General Brigham | Health system buyer | Major Boston health system with research, cardiology, and population health needs | massgeneralbrigham.org | VP Population Health, Director of Clinical Research, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Brigham and Women’s Hospital | Academic medical center | Strong cardiology, epidemiology, and clinical research alignment | brighamandwomens.org | Research Director, Cardiology Chair, Clinical Trial Manager | Strong Market Fit, Attendance Not Confirmed |
| Harvard T.H. Chan School of Public Health | Academic / public health institution | Relevant to epidemiology, prevention science, and research partnerships | hsph.harvard.edu | Professor, Department Chair, Research Administrator | Strong Market Fit, Attendance Not Confirmed |
| Boston University School of Public Health | Academic institution | Epidemiology and health behavior research alignment | bu.edu/sph | Faculty Lead, Research Director, Grants Manager | Strong Market Fit, Attendance Not Confirmed |
| Dana-Farber Cancer Institute | Research hospital / clinical research organization | Evidence-driven care and preventive health research needs | dana-farber.org | Clinical Research Director, Procurement Lead, Data Analytics Director | Strong Market Fit, Attendance Not Confirmed |
| Pfizer | Pharmaceutical company | Cardiometabolic pipeline, evidence generation, and medical affairs relevance | pfizer.com | Medical Affairs Director, R&D Lead, Scientific Communications Manager | Strong Market Fit, Attendance Not Confirmed |
| Novartis | Pharmaceutical company | Cardiovascular and metabolic disease interest makes this a strong scientific audience fit | novartis.com | Medical Director, Market Access Lead, Clinical Development Director | Strong Market Fit, Attendance Not Confirmed |
| Medtronic | Medical device company | Cardiovascular technologies and outcomes-focused clinical engagement relevance | medtronic.com | Strategic Marketing Director, Medical Affairs, Clinical Evidence Lead | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Health system / research hospital | Large cardiology and preventive medicine buyer with research and procurement influence | clevelandclinic.org | Director of Procurement, Cardiology Administrator, Research Operations Manager | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Health system / research institution | High-value target for clinical research, outcomes, and preventive care offerings | mayoclinic.org | Medical Director, Research Program Manager, Supply Chain Director | Strong Market Fit, Attendance Not Confirmed |
| UnitedHealth Group | Payer / healthcare services organization | Population health, analytics, and preventive care investment relevance | unitedhealthgroup.com | VP Population Health, Clinical Strategy Director, Analytics Leader | Strong Market Fit, Attendance Not Confirmed |
| Centers for Disease Control and Prevention (CDC) | Government health agency | Public health surveillance, prevention science, and policy relevance | cdc.gov | Program Director, Epidemiologist, Procurement Specialist | Strong Market Fit, Attendance Not Confirmed |
| National Institutes of Health (NIH) | Government research agency | Research funding, scientific collaboration, and data-oriented outreach relevance | nih.gov | Program Officer, Research Director, Contracting Officer | Strong Market Fit, Attendance Not Confirmed |
| AstraZeneca | Pharmaceutical company | Cardiometabolic and evidence-generation alignment | astrazeneca.com | Medical Affairs Lead, Clinical Operations Director, Insights Manager | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer / Chief Scientific Officer | Executive / Medical Affairs | C-level | Sets research priorities and partnership direction |
| 2 | VP / Director of Clinical Research | Research / R&D | VP / Director | Owns study planning, vendor selection, and research partnerships |
| 3 | Director of Population Health | Population Health / Quality | Director | Evaluates prevention, analytics, and care management solutions |
| 4 | Director of Epidemiology / Biostatistics | Research / Public Health | Director | Key for data, methodology, surveillance, and evidence services |
| 5 | Procurement Manager / Strategic Sourcing Manager | Procurement / Supply Chain | Manager | Vendor and contract ownership for research, clinical, and technology purchases |
| 6 | Medical Affairs Director / Scientific Communications Manager | Medical Affairs | Director / Manager | Supports scientific exchange, publication strategy, and conference engagement |
| 7 | Clinical Operations Manager / Trial Manager | Clinical Operations | Manager | Buys tools and services for study execution and patient tracking |
| 8 | Health IT Director / Analytics Director | IT / Data / Digital Health | Director | Influences analytics, AI, interoperability, and workflow platforms |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core buyer base for prevention, cardiology, and research-enabled care | Clinical solutions, procurement, analytics, and care delivery tools |
| 2 | Pharmaceuticals | Drug developers interested in cardiometabolic evidence and education | Medical affairs, clinical development, market access |
| 3 | Medical Devices | Strong fit for cardiovascular technology and outcomes discussions | Clinical evidence, product education, and KOL engagement |
| 4 | Biotechnology | Relevant for translational science and biomarker-driven prevention | Research collaboration and scientific positioning |
| 5 | Public Health | Prevention and epidemiology are central themes | Surveillance, prevention campaigns, and population tools |
| 6 | Information Technology & Services | Digital health, data integration, and analytics are highly relevant | EHR, interoperability, dashboards, AI, and reporting tools |
| 7 | Research | Scientific audience is research-heavy by design | Data services, research tools, and study support |
| 8 | Government Administration | Public health agencies and funding bodies are likely stakeholders | Policy, grant, and procurement outreach |
| 9 | Financial Services | Health plans and payer organizations influence prevention adoption | Value-based care, utilization, and population health programs |
| 10 | Nonprofit Organization Management | Health foundations and advocacy groups often participate in prevention events | Partnerships, sponsorships, mission-aligned solutions |
| 11 | Education Management | Academic institutions are a major attendee group | Research, curriculum, and faculty outreach |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed by the organizer | Confirmed unavailable | Official event page provided did not include an attendance number | Avoid using unverified attendance claims in outreach |
| Exhibitor count | Not publicly confirmed | Unavailable | No exhibitor directory in provided official text | Likely limited compared with large commercial expos |
| Buyer count | Not publicly confirmed | Unavailable | No buyer list provided publicly in source text | High scientific and institutional buyer potential |
| Speaker count | Not publicly confirmed | Unavailable | No agenda/speaker roster in provided text | Speaker roster should be checked on the live agenda page when available |
| Historical attendance | Not provided in supplied source material | Unavailable | No official historical attendance figure included in the copied content | Use organizer media kit or archived registration pages for validation |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Epidemiology | Data, cohort management, statistical methods, surveillance | Methodology partnerships and research support conversations | Analytics platforms, research services, study design support |
| Prevention science | Evidence-based intervention models and outcomes tracking | Clinical and population health solution demos | Population health software, care management, education programs |
| Cardiometabolic health | Integrated solutions for cardiovascular and metabolic disease | Targeted scientific messaging to specialists and health systems | Diagnostics, drugs, monitoring, digital coaching tools |
| Clinical research | Operational efficiency, recruitment, compliance, data capture | Vendor meetings with trial teams and research offices | CRO services, eClinical tools, patient engagement platforms |
| Public health | Surveillance, prevention campaigns, equity, community health | Agency and foundation outreach, policy collaboration | Dashboards, outreach platforms, measurement tools |
| Digital health and analytics | AI, predictive modeling, interoperability, reporting | Decision-maker meetings with IT and innovation leaders | Data platforms, patient risk tools, workflow automation |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | The event attracts scientific, clinical, public health, and research stakeholders with purchasing influence |
| Decision-maker availability | High | Likely presence of directors, VPs, and senior scientific leaders across health systems and industry |
| Data collection potential | Medium | Useful for thought leadership and relationship building, but no public attendee list is confirmed in the supplied content |
| Apollo targeting potential | Very High | Clear fit for health systems, pharma, medtech, research, and public health filters |
| Geographic targeting potential | High | Boston and the Northeast corridor contain many relevant buyers and institutions |
| Best outreach approach | High-touch account-based outreach | Target scientific leaders, procurement, and innovation teams with prevention and outcomes messaging |
| Overall lead quality | High | Strong event for healthcare and life-sciences lead generation, especially for evidence-based offerings |
| Best use case | Attendee list building, ABM, sponsorship prospecting, scientific partnership outreach | Best suited for vendors selling to clinicians, researchers, health systems, and pharmaceutical teams |
| Limitations / risks | Limited public attendee transparency | No public attendance figure or official participant list was present in the provided page content |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Pharmaceuticals; Medical Devices; Biotechnology; Research; Public Health; Information Technology & Services; Financial Services; Government Administration; Education Management | Prioritize the most relevant buyer ecosystems for prevention and cardiometabolic science |
| Departments | Medical Affairs; Research; Clinical Operations; Procurement; Supply Chain; Population Health; Quality; IT; Data / Analytics; Business Development | Reach the functions most likely to buy, influence, or sponsor solutions |
| Seniority | Director; VP; CXO; Head; Manager; Principal | Focus on decision-makers and senior influencers |
| Job titles | Chief Medical Officer, Chief Scientific Officer, VP Clinical Research, Director of Epidemiology, Director of Population Health, Procurement Manager, Medical Affairs Director, Research Director, Clinical Operations Manager, Analytics Director | Target highest-fit titles for conference outreach and post-event follow-up |
| Geography | Boston; Massachusetts; Northeast U.S.; National U.S.; select global hubs | Align with host-market concentration and broader national audience |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001+ | Covers research institutions, health systems, and large life-science enterprises |
| Keywords | cardiometabolic, epidemiology, prevention, population health, clinical research, cardiovascular, lifestyle medicine, outcomes, public health, biomarker | Increase precision in search and list building |
| Technologies | EHR, clinical trial software, population health platforms, data visualization, AI analytics, remote patient monitoring | Useful if selling software, services, or integration support |
| Company type | Enterprise; Nonprofit; Academic; Government; Healthcare Provider; Life Sciences | Matches the likely attendee mix |
| Revenue range | Flexible; prioritize larger healthcare and life-sciences organizations where appropriate | Supports account-based targeting for enterprise buyers |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| American Heart Association – EPI/Lifestyle official page | Official organizer source | Event name, scientific positioning, and March 1–4, 2027 date | Very High |
| American Heart Association professional meetings hub | Official organizer website | Organizer identity and event family context within AHA scientific meetings | High |
| heart.org | Official association website | Organizer brand verification and institutional scope | High |
| Meet Boston | Destination / venue-market context | Host-city context for Boston business and healthcare ecosystem | Medium |
| Mass General Brigham | Buyer organization reference | Health-system buyer profile relevant to cardiovascular prevention and research | High |
| U.S. Department of Health & Human Services | Government context source | Public-health buyer ecosystem relevance for federal outreach | Medium |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to EPI/Lifestyle - Epidemiology & Prevention, Lifestyle & Cardiometabolic Health Scientific Sessions — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.